Search

Your search keyword '"Bartolomé, R"' showing total 517 results
Start Over Author "Bartolomé, R"
517 results on '"Bartolomé, R"'

2. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

Author

Agusti, Alvar, Lopez-Campos, José Luis, Miravitlles, Marc, Soler-Cataluña, Juan Jose, Marin, Jose Maria, Cosio, Borja G., Alcázar-Navarrete, Bernardino, Echave-Sustaeta, Jose Maria, Casanova, Ciro, Peces-Barba, German, de-Torres, Juan Pablo, Fernandez-Villar, Alberto, Ancochea, Julio, Villar-Alvarez, Felipe, Roman-Rodriguez, Miguel, Molina, Jesus, Garcia-Rivero, Juan Luis, Gonzalez, Cruz, Sobradillo, Patricia, Faner, Rosa, Peña, Carolina, Sharma, Raj, Izquierdo, José Luis, and Celli, Bartolome R.

Published
2024
Full Text
View/download PDF

4. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

Author

de-Torres, Juan P., Casanova, Ciro, Marín, José M., Cabrera, Carlos, Marín, Marta, Ezponda, Ana, Cosio, Borja G., Martínez, Cristina, Solanes, Ingrid, Fuster, Antonia, Calle, Myriam, Peces-Barba, Germán, Gotera, Carolina, Feu-Collado, Nuria, Marin, Alicia, Alcaide, Ana Belén, Sangro, Matilde, Bastarrika, Gorka, and Celli, Bartolome R.

Published
2024
Full Text
View/download PDF

6. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

Author

Agustí, Alvar, Celli, Bartolome R., Criner, Gerard J., Halpin, David, Anzueto, Antonio, Barnes, Peter, Bourbeau, Jean, Han, MeiLan K., Martinez, Fernando J., Montes de Oca, Maria, Mortimer, Kevin, Papi, Alberto, Pavord, Ian, Roche, Nicolas, Salvi, Sundeep, Sin, Don D., Singh, Dave, Stockley, Robert, López Varela, M. Victorina, Wedzicha, Jadwiga A., and Vogelmeier, Claus F.

Published
2023
Full Text
View/download PDF

7. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial

Author

Tashkin, Donald P, Miravitlles, Marc, Celli, Bartolomé R, Metzdorf, Norbert, Mueller, Achim, Halpin, David MG, and Anzueto, Antonio

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Pneumonia & Influenza, Pneumonia, Lung, Clinical Research, Respiratory, Administration, Inhalation, Adrenal Cortex Hormones, Aged, Bronchodilator Agents, Double-Blind Method, Female, Fluticasone, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive, Research Design, Risk Factors, Tiotropium Bromide, COPD, Inhaled corticosteroids, Fluticasone propionate, UPLIFT, UPLIFT®, Cardiorespiratory Medicine and Haematology, Respiratory System, Cardiovascular medicine and haematology, Clinical sciences
Abstract

BackgroundUse of inhaled corticosteroids (ICS) increases the risk of pneumonia in chronic obstructive pulmonary disease (COPD), but the magnitude of risk with different ICS remains unclear.MethodsA post hoc analysis of the 4-year UPLIFT® trial to assess whether pneumonia risk differed by type of ICS (fluticasone propionate [FP], other ICS, or no ICS) in permanent users (defined by use until end of study) or in users at baseline (sensitivity analysis).ResultsFor the permanent-users analysis, 825 patients receiving FP throughout the trial, 825 patients receiving other ICS and 825 patients not receiving ICS were matched on relevant baseline features 1:1:1. A significantly greater risk of pneumonia was observed for FP versus no ICS: the hazard ratio (HR) for risk of pneumonia was 1.33 (95% confidence interval [CI] 1.00, 1.75; p = 0.046) and the rate ratio (RR) was 1.58 (95% CI 1.05, 2.37; p = 0.028). A greater risk was also found for FP versus other ICS: HR 1.28 (95% CI 0.97, 1.68; p = 0.078) and RR 1.48 (95% CI 1.00, 2.19; p = 0.049). A higher proportion of patients on FP were hospitalized with pneumonia (7.9%) versus other ICS (6.7%) or no ICS (5.9%). Whilst other ICS use was associated with the highest number of fatal pneumonia events, the total number of fatal pneumonia incidents was low. A similar pattern was observed in the sensitivity analyses, which included 4002 patients on different treatments at baseline (FP, other ICS, and no ICS) and considered potential switches during the study.ConclusionThe results support existing evidence of an increased pneumonia risk with FP use compared with other ICS and no ICS use in patients with COPD. Healthcare professionals should evaluate the risk-benefit ratio of using ICS when making treatment decisions with their patients.Trial registrationPost hoc analysis of UPLIFT®. ClinicalTrials.gov number: NCT00144339 . Retrospectively registered September 2, 2005.

Published
2018

8. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

Author

Rabe, Klaus F, Celli, Bartolome R, Wechsler, Michael E, Abdulai, Raolat M, Luo, Xiaodong, Boomsma, Maarten M, Staudinger, Heribert, Horowitz, Julie E, Baras, Aris, Ferreira, Manuel A, Ruddy, Marcella K, Nivens, Michael C, Amin, Nikhil, Weinreich, David M, Yancopoulos, George D, and Goulaouic, Helene

Published
2021
Full Text
View/download PDF

9. Optimal NIV Medicare Access Promotion: Patients With Central Sleep Apnea: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society

Author

Gay, Peter C., Owens, Robert L., Wolfe, Lisa F., Benditt, Joshua O., Aboussouan, Loutfi S., Coleman, John M., III, Hess, Dean R., Hill, Nicholas S., Criner, Gerard J., Branson, Richard D., Celli, Bartolome R., MacIntyre, Neil R., Sergew, Amen, Morgenthaler, Timothy I., Malhotra, Atul, Berry, Richard B., Johnson, Karin G., Raphaelson, Marc I., Mokhlesi, Babak, Won, Christine H., Selim, Bernardo J., Make, Barry J., Sunwoo, Bernie Y., Collop, Nancy A., Patil, Susheel P., Chediak, Alejandro D., Olson, Eric J., Vohra, Kunwar Praveen, and Raphaelson, Marc

Published
2021
Full Text
View/download PDF

10. Optimal NIV Medicare Access Promotion: Patients With Thoracic Restrictive Disorders: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society

Author

Gay, Peter C., Owens, Robert L., Wolfe, Lisa F., Benditt, Joshua O., Aboussouan, Loutfi S., Coleman, John M., III, Hess, Dean R., Hill, Nicholas S., Criner, Gerard J., Branson, Richard D., Celli, Bartolome R., MacIntyre, Neil R., Sergew, Amen, Morgenthaler, Timothy I., Malhotra, Atul, Berry, Richard B., Johnson, Karin G., Raphaelson, Marc I., Mokhlesi, Babak, Won, Christine H., Selim, Bernardo J., Make, Barry J., Sunwoo, Bernie Y., Collop, Nancy A., Patil, Susheel P., Chediak, Alejandro D., Olson, Eric J., Vohra, Kunwar Praveen, and Aboussouan, Loutfi

Published
2021
Full Text
View/download PDF

11. Optimal NIV Medicare Access Promotion: Patients With OSA: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society

Author

Gay, Peter C., Owens, Robert L., Wolfe, Lisa F., Benditt, Joshua O., Aboussouan, Loutfi S., Coleman, John M., III, Hess, Dean R., Hill, Nicholas S., Criner, Gerard J., Branson, Richard D., Celli, Bartolome R., MacIntyre, Neil R., Sergew, Amen, Morgenthaler, Timothy I., Malhotra, Atul, Berry, Richard B., Johnson, Karin G., Raphaelson, Marc I., Mokhlesi, Babak, Won, Christine H., Selim, Bernardo J., Make, Barry J., Sunwoo, Bernie Y., Collop, Nancy A., Patil, Susheel P., Chediak, Alejandro D., Olson, Eric J., and Vohra, Kunwar Praveen

Published
2021
Full Text
View/download PDF

12. Optimal NIV Medicare Access Promotion: Patients With Hypoventilation Syndromes: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society

Author

Gay, Peter C., Owens, Robert L., Wolfe, Lisa F., Benditt, Joshua O., Aboussouan, Loutfi S., Coleman, John M., III, Hess, Dean R., Hill, Nicholas S., Criner, Gerard J., Branson, Richard D., Celli, Bartolome R., MacIntyre, Neil R., Sergew, Amen, Morgenthaler, Timothy I., Malhotra, Atul, Berry, Richard B., Johnson, Karin G., Raphaelson, Marc I., Mokhlesi, Babak, Won, Christine H., Selim, Bernardo J., Make, Barry J., Sunwoo, Bernie Y., Collop, Nancy A., Patil, Susheel P., Chediak, Alejandro D., Olson, Eric J., and Vohra, Kunwar Praveen

Published
2021
Full Text
View/download PDF

13. Optimal NIV Medicare Access Promotion: Patients With COPD: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society

Author

Gay, Peter C., Owens, Robert L., Wolfe, Lisa F., Benditt, Joshua O., Aboussouan, Loutfi S., Coleman, John M., III, Hess, Dean R., Hill, Nicholas S., Criner, Gerard J., Branson, Richard D., Celli, Bartolome R., MacIntyre, Neil R., Sergew, Amen, Morgenthaler, Timothy I., Malhotra, Atul, Berry, Richard B., Johnson, Karin G., Raphaelson, Marc I., Mokhlesi, Babak, Won, Christine H., Selim, Bernardo J., Make, Barry J., Sunwoo, Bernie Y., Collop, Nancy A., Patil, Susheel P., Chediak, Alejandro D., Olson, Eric J., and Vohra, Kunwar Praveen

Published
2021
Full Text
View/download PDF

14. Executive Summary: Optimal NIV Medicare Access Promotion: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society

Author

Gay, Peter C., Owens, Robert L., Wolfe, Lisa F., Benditt, Joshua O., Aboussouan, Loutfi S., Coleman, John M., III, Hess, Dean R., Hill, Nicholas S., Criner, Gerard J., Branson, Richard D., Celli, Bartolome R., MacIntyre, Neil R., Sergew, Amen, Morgenthaler, Timothy I., Malhotra, Atul, Berry, Richard B., Johnson, Karin G., Raphaelson, Marc I., Mokhlesi, Babak, Won, Christine H., Selim, Bernardo J., Make, Barry J., Sunwoo, Bernie Y., Collop, Nancy A., Patil, Susheel P., Chediak, Alejandro D., Olson, Eric J., and Vohra, Kunwar Praveen

Published
2021
Full Text
View/download PDF

17. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

Author

Casanova, Ciro, Gonzalez-Dávila, Enrique, Martínez-Gonzalez, Cristina, Cosio, Borja G., Fuster, Antonia, Feu, Nuria, Solanes, Ingrid, Cabrera, Carlos, Marin, José M., Balcells, Eva, Peces-Barba, Germán, de Torres, Juan P., Marín-Oto, Marta, Calle, Myriam, Golpe, Rafael, Ojeda, Elena, Divo, Miguel, Pinto-Plata, Victor, Amado, Carlos, López-Campos, José Luis, and Celli, Bartolome R.

Published
2021
Full Text
View/download PDF

19. Sex differences between women and men with COPD: A new analysis of the 3CIA study

Author

Perez, Tamara Alonso, Castillo, Elena García, Ancochea, Julio, Pastor Sanz, María Teresa, Almagro, Pere, Martínez-Camblor, Pablo, Miravitlles, Marc, Rodríguez-Carballeira, Mónica, Navarro, Annie, Lamprecht, Bernd, Ramírez-García Luna, Ana S., Kaiser, Bernhard, Alfageme, Inmaculada, Casanova, Ciro, Esteban, Cristóbal, Soler-Cataluña, Juan J., De-Torres, Juan P., Celli, Bartolomé R., Marin, Jose M., Lopez-Campos, Jose L., Riet, Gerben Ter, Sobradillo, Patricia, Lange, Peter, Garcia-Aymerich, Judith, Anto, Josep M., Turner, Alice M., Han, MeiLan K., Langhammer, Arnulf, Sternberg, Alice, Leivseth, Linda, Bakke, Per, Johannessen, Ane, Oga, Toru, Cosío, Borja, Echazarreta, Andres, Roche, Nicolas, Burgel, Pierre-Régis, Sin, Don D., Puhan, Milo A., and Soriano, Joan B.

Published
2020
Full Text
View/download PDF

22. Norovirus detection in environmental samples in norovirus outbreaks in closed and semi-closed settings

Author

Alsedà, M., Álvarez, J., Barrabeig, I., Belver, A.I., Camps, N., Minguell, S., Carol, M., Godoy, P., Izquierdo, C., Jané, M., Martínez, A., Parrón, I., Pérez, C., Rico, E., Girón, F., Pedrol, A., Camp, J., Macià, A., Marcos de Miguel, J., Campo, A., Rovira, A., Sabaté, M., Sala, M.R., Torner, N., Vileu, R.M., de Andrés, A., Cunillé, M., Forns, M.L., Razquín, E., Sabaté, S., de Simón, M., Rius, C., de Benito, J., Camprubí, E., Moreno-Martínez, A., Bartolomé, R., Cornejo, T., Guix, S., Coronas, L., Domínguez, À., Soldevila, N., Belver, A., Razquin, E., and Domínguez, A.

Published
2020
Full Text
View/download PDF

25. Enhancing earthquake location in deep ocean environments with DAS

Author

Latorre, H, Bozzi, E, Ventosa, S, Armas, M, Vidal-Moreno, P, Villaseñor, A, Bartolomé, R, Ugalde, A, Latorre, Hugo, Bozzi, Emanuele, Ventosa, Sergi, Armas, Melania Cubas, Vidal-Moreno, Pedro, Villaseñor, Antonio, Bartolomé, Rafael, Ugalde, Arantza, Latorre, H, Bozzi, E, Ventosa, S, Armas, M, Vidal-Moreno, P, Villaseñor, A, Bartolomé, R, Ugalde, A, Latorre, Hugo, Bozzi, Emanuele, Ventosa, Sergi, Armas, Melania Cubas, Vidal-Moreno, Pedro, Villaseñor, Antonio, Bartolomé, Rafael, and Ugalde, Arantza

Published
2024

30. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data

Author

Elena García Castillo, Tamara Alonso Pérez, Julio Ancochea, Maria Teresa Pastor Sanz, Pere Almagro, Pablo Martínez-Camblor, Marc Miravitlles, Mónica Rodríguez-Carballeira, Annie Navarro, Bernd Lamprecht, Ana S. Ramírez-García Luna, Bernhard Kaiser, Inmaculada Alfageme, Ciro Casanova, Cristóbal Esteban, Juan J. Soler-Cataluña, Juan P. de-Torres, Bartolomé R. Celli, Jose M. Marín, Gerben ter Riet, Patricia Sobradillo, Peter Lange, Judith Garcia-Aymerich, Josep M. Anto, Alice M. Turner, MeiLan K. Han, Arnulf Langhammer, Sigrid Anna Aalberg Vikjord, Alice Sternberg, Linda Leivseth, Per Bakke, Ane Johannessen, Toru Oga, Borja G. Cosío, Andrés Echazarreta, Nicolás Roche, Pierre-Régis Burgel, Don D. Sin, Milo A. Puhan, Jose Luis López-Campos, Laura Carrasco, and Joan B. Soriano

Subjects
Medicine
Abstract

In 2019, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) modified the grading system for patients with COPD, creating 16 subgroups (1A–4D). As part of the COPD Cohorts Collaborative International Assessment (3CIA) initiative, we aim to compare the mortality prediction of the 2015 and 2019 COPD GOLD staging systems. We studied 17 139 COPD patients from the 3CIA study, selecting those with complete data. Patients were classified by the 2015 and 2019 GOLD ABCD systems, and we compared the predictive ability for 5-year mortality of both classifications. In total, 17 139 patients with COPD were enrolled in 22 cohorts from 11 countries between 2003 and 2017; 8823 of them had complete data and were analysed. Mean±sd age was 63.9±9.8 years and 62.9% were male. GOLD 2019 classified the patients in milder degrees of COPD. For both classifications, group D had higher mortality. 5-year mortality did not differ between groups B and C in GOLD 2015; in GOLD 2019, mortality was greater for group B than C. Patients classified as group A and B had better sensitivity and positive predictive value with the GOLD 2019 classification than GOLD 2015. GOLD 2015 had better sensitivity for group C and D than GOLD 2019. The area under the curve values for 5-year mortality were only 0.67 (95% CI 0.66–0.68) for GOLD 2015 and 0.65 (95% CI 0.63–0.66) for GOLD 2019. The new GOLD 2019 classification does not predict mortality better than the previous GOLD 2015 system.

Published
2020
Full Text
View/download PDF

31. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial

Author

Donald P. Tashkin, Marc Miravitlles, Bartolomé R. Celli, Norbert Metzdorf, Achim Mueller, David M. G. Halpin, and Antonio Anzueto

Subjects
COPD, Pneumonia, Inhaled corticosteroids, Fluticasone propionate, UPLIFT®, Diseases of the respiratory system, RC705-779
Abstract

Abstract Background Use of inhaled corticosteroids (ICS) increases the risk of pneumonia in chronic obstructive pulmonary disease (COPD), but the magnitude of risk with different ICS remains unclear. Methods A post hoc analysis of the 4-year UPLIFT® trial to assess whether pneumonia risk differed by type of ICS (fluticasone propionate [FP], other ICS, or no ICS) in permanent users (defined by use until end of study) or in users at baseline (sensitivity analysis). Results For the permanent-users analysis, 825 patients receiving FP throughout the trial, 825 patients receiving other ICS and 825 patients not receiving ICS were matched on relevant baseline features 1:1:1. A significantly greater risk of pneumonia was observed for FP versus no ICS: the hazard ratio (HR) for risk of pneumonia was 1.33 (95% confidence interval [CI] 1.00, 1.75; p = 0.046) and the rate ratio (RR) was 1.58 (95% CI 1.05, 2.37; p = 0.028). A greater risk was also found for FP versus other ICS: HR 1.28 (95% CI 0.97, 1.68; p = 0.078) and RR 1.48 (95% CI 1.00, 2.19; p = 0.049). A higher proportion of patients on FP were hospitalized with pneumonia (7.9%) versus other ICS (6.7%) or no ICS (5.9%). Whilst other ICS use was associated with the highest number of fatal pneumonia events, the total number of fatal pneumonia incidents was low. A similar pattern was observed in the sensitivity analyses, which included 4002 patients on different treatments at baseline (FP, other ICS, and no ICS) and considered potential switches during the study. Conclusion The results support existing evidence of an increased pneumonia risk with FP use compared with other ICS and no ICS use in patients with COPD. Healthcare professionals should evaluate the risk–benefit ratio of using ICS when making treatment decisions with their patients. Trial registration Post hoc analysis of UPLIFT®. ClinicalTrials.gov number: NCT00144339. Retrospectively registered September 2, 2005.

Published
2018
Full Text
View/download PDF

34. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

Author

Vogelmeier, Claus F., Criner, Gerard J., Martinez, Fernando J., Anzueto, Antonio, Barnes, Peter J., Bourbeau, Jean, Celli, Bartolome R., Chen, Rongchang, Decramer, Marc, Fabbri, Leonardo M., Frith, Peter, Halpin, David M.G., Varela, M. Victorina López, Nishimura, Masaharu, Roche, Nicolas, Rodriguez-Roisin, Roberto, Sin, Don D., Singh, Dave, Stockley, Robert, Vestbo, Jørgen, Wedzicha, Jadwiga A., and Agusti, Alvar

Published
2017
Full Text
View/download PDF

35. Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD

Author

Vogelmeier, Claus F., Criner, Gerard J., Martínez, Fernando J., Anzueto, Antonio, Barnes, Peter J., Bourbeau, Jean, Celli, Bartolome R., Chen, Rongchang, Decramer, Marc, Fabbri, Leonardo M., Frith, Peter, Halpin, David M.G., López Varela, M. Victorina, Nishimura, Masaharu, Roche, Nicolás, Rodríguez-Roisin, Roberto, Sin, Don D., Singh, Dave, Stockley, Robert, Vestbo, Jørgen, Wedzicha, Jadwiga A., and Agustí, Alvar

Published
2017
Full Text
View/download PDF

37. Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study

Author

Andrianopoulos, Vasileios, Celli, Bartolome R., Franssen, Frits M.E., Pinto-Plata, Victor M., Calverley, Peter M.A., Vanfleteren, Lowie E.G.W., Vogiatzis, Ioannis, Vestbo, Jørgen, Agusti, Alvar, Bakke, Per S., Rennard, Stephen I., MacNee, William, Tal-Singer, Ruth, Yates, Julie C., Wouters, Emiel F.M., and Spruit, Martijn A.

Published
2016
Full Text
View/download PDF

45. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data

Author

Soriano, Joan B, Lamprecht, Bernd, Ramírez, Ana S, Martinez-Camblor, Pablo, Kaiser, Bernhard, Alfageme, Inmaculada, Almagro, Pere, Casanova, Ciro, Esteban, Cristobal, Soler-Cataluña, Juan J, de-Torres, Juan P, Miravitlles, Marc, Celli, Bartolome R, Marin, Jose M, Puhan, Milo A, Sobradillo, Patricia, Lange, Peter, Sternberg, Alice L, Garcia-Aymerich, Judith, Turner, Alice M, Han, MeiLan K, Langhammer, Arnulf, Leivseth, Linda, Bakke, Per, Johannessen, Ane, Roche, Nicolas, and Sin, Don D

Published
2015
Full Text
View/download PDF

46. Executive Summary: Prevention of Acute Exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

Author

Criner, Gerard J., Bourbeau, Jean, Diekemper, Rebecca L., Ouellette, Daniel R., Goodridge, Donna, Hernandez, Paul, Curren, Kristen, Balter, Meyer S., Bhutani, Mohit, Camp, Pat G., Celli, Bartolome R., Dechman, Gail, Dransfield, Mark T., Fiel, Stanley B., Foreman, Marilyn G., Hanania, Nicola A., Ireland, Belinda K., Marchetti, Nathaniel, Marciniuk, Darcy D., Mularski, Richard A., Ornelas, Joseph, Road, Jeremy D., and Stickland, Michael K.

Published
2015
Full Text
View/download PDF

47. Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

Author

Criner, Gerard J., Bourbeau, Jean, Diekemper, Rebecca L., Ouellette, Daniel R., Goodridge, Donna, Hernandez, Paul, Curren, Kristen, Balter, Meyer S., Bhutani, Mohit, Camp, Pat G., Celli, Bartolome R., Dechman, Gail, Dransfield, Mark T., Fiel, Stanley B., Foreman, Marilyn G., Hanania, Nicola A., Ireland, Belinda K., Marchetti, Nathaniel, Marciniuk, Darcy D., Mularski, Richard A., Ornelas, Joseph, Road, Jeremy D., and Stickland, Michael K.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results